HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiangyang Long Selected Research

Neoplasm Metastasis (Metastasis)

1/2022Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
11/2012β-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiangyang Long Research Topics

Disease

3Neoplasms (Cancer)
01/2022 - 11/2012
3Sepsis (Septicemia)
10/2018 - 07/2013
2Neoplasm Metastasis (Metastasis)
01/2022 - 11/2012
2Inflammation (Inflammations)
10/2018 - 07/2013
1Necrosis
07/2013
1Carcinoma (Carcinomatosis)
11/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2012

Drug/Important Bio-Agent (IBA)

3salicylhydroxamic acid (SHAM)IBA
10/2018 - 07/2013
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
10/2018 - 08/2014
1NitrogenIBA
10/2018
1propargylglycineIBA
10/2018
1CreatinineIBA
10/2018
1Eosine Yellowish-(YS) (Eosin)IBA
10/2018
1Hematoxylin (Haematoxylon)IBA
10/2018
1Urea (Carbamide)FDA LinkGeneric
10/2018
1Interleukin-6 (Interleukin 6)IBA
10/2018
1CytokinesIBA
10/2018
1sodium bisulfide (NaHS)IBA
08/2014
1Interleukin-10 (Interleukin 10)IBA
08/2014
1ImmunosorbentsIBA
07/2013
1urinastatin (MR 20)IBA
07/2013
1InterleukinsIBA
07/2013
1Nucleic AcidsIBA
11/2012
1Antineoplastic Agents (Antineoplastics)IBA
11/2012
1SurvivinIBA
11/2012
1elemeneIBA
11/2012

Therapy/Procedure

1Immunotherapy
01/2022